Nick Devoogdt

29PUBLICATIONS
135CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapyMedical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Oct 29, 2025
Design and Preclinical Validation of an Anti-B7-H3-Specific Radiotracer: A Non-Invasive Imaging Tool to Guide B7-H3-Targeted Therapies.

Cyprine Neba Funeh, Fien Meeus, Niels Van Winnendael

|Sep 17, 2025
Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy.

Sana M Arnouk, Daliya Kancheva, Helena Van Damme

|Aug 01, 2025
Immune modulation following α and β<sup>-</sup> radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model.

Hannelore Ceuppens, Kirsten De Ridder, Thomas Ertveldt

|May 10, 2025
VSIG4-Expressing Macrophages Contribute to Antiparasitic and Antimetastatic Responses in the Peritoneal Cavity.

Els Lebegge, Daliya Kancheva, Jolien Van Craenenbroeck

|Dec 18, 2024
Imaging of tumor-associated macrophage dynamics during immunotherapy using a CD163-specific nanobody-based immunotracer.

Yoline Lauwers, Timo W M De Groof, Cécile Vincke

|Nov 19, 2024
Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity.

Fien Meeus, Cyprine Neba Funeh, Robin Maximilian Awad

Pageof 5

Frequent Collaborators

8 joint publications

Karine Breckpot

7 joint publications

Timo W M De Groof

7 joint publications

Marleen Keyaerts

5 joint publications

Quentin Lecocq